Terray Therapeutics

Terray Therapeutics is a biotechnology company that propels drug discovery into the information age. It is led by leaders in artificial intelligence, synthetic (medicinal) chemistry, biology, preclinical development, automation, and nanotechnology. Chemical datasets generated with its novel ultra-dense microarray technology integrate seamlessly with its integrated machine learning and computational platform to map biochemical interactions between small molecules and disease causes. AI and machine learning models are powered by iterative cycles of virtual molecular design and experimentation, which in turn guide the next design cycle. The company was founded in 2018 and is based in Pasadena, California.